Difference between revisions of "Paul McKay"
From QueerBio.com
(Created page with "Paul McKay ==Country== ==Birth - Death== ==Occupation== Scientist ==Description== Senior researcher working on the mucosal vac...") |
|||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
| − | [[File: | + | [[File:paulmckay.jpg|200px|thumb|left|Paul McKay]] |
==Country== | ==Country== | ||
| + | Great Britain | ||
==Birth - Death== | ==Birth - Death== | ||
| Line 14: | Line 15: | ||
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue. | Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue. | ||
| + | |||
| + | ==See Also== | ||
| + | |||
| + | * [[LGBTQ Participants in Pharmaceutical, Vaccine and Biotech Studies]] | ||
==Further Reading/Research== | ==Further Reading/Research== | ||
Latest revision as of 20:41, 19 September 2021
Country
Great Britain
Birth - Death
Occupation
Scientist
Description
Senior researcher working on the mucosal vaccinology team in the Department of Medicine, Imperial College London. Team member who developed the COVID-19 vaccine in 2020/2021. His primary research centres on the development of new vaccine candidates, the optimization of immunization regimens and the assessment of potential vaccine efficacy, with a particular focus on the generation of vaccine-induced immunity at the surface and within mucosal tissue.
